Stockreport

Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer [Yahoo! Finance]

Pyxis Oncology, Inc.  (PYXS) 
PDF developing antibody-based KnotBody® drugs for ion channel and G protein coupled receptor (GPCR)-driven diseases, today announces the appointment of Joel Edwards as Chief [Read more]